Test 2 GI Meds Flashcards
(35 cards)
1
Q
famotidine: class
A
- H2 receptor antagonist
2
Q
famotidine: MOA
A
- binds to H2 R and blocks it, so suppresses secretion of gastric acid
3
Q
famotidine: indications
A
- tx and prevention of duodenal ulcers
- tx of gastric ulcers
- GERD
- ZE Syndrome (hypersecretory states)
- OTC: heartburn, acid indigestion, sour stomach
4
Q
famotidine: SEs
A
- elevation of gastric pH may inc risk of pneumonia
- **no antiandrogenic effects b/c does not bind to androgen Rs
5
Q
famotidine: ADRs
A
- arrhythmias
- agranulocytosis
- aplastic anemia
6
Q
ranitidine: class
A
- H2 receptor antagonist
7
Q
ranitidine: MOA
A
- H2 receptor blocker that suppresses secretion of gastric acid from parietal cells
8
Q
ranitidine: indications
A
- short term tx of gastric/duodenal ulcers
- prophylaxis of recurrent duodenal ulcers
- tx of ZE Syndrome: better than cimetidine
- tx of GERD
9
Q
ranitidine: SEs
A
- rare CNS effects: b/c penetrates BBB poorly
- **no antiandrogenic effects b/c does not bind to androgen Rs
10
Q
ranitidine: ADRs
A
- arrhythmias
- agranulocytosis
- aplastic anemia
11
Q
H2 receptor antagonist: nursing implications
A
- may be taken w/o regard to meals
- make sure pt knows the dosing schedule
- avoid cigarettes and aspirin/NSAIDs
- advise pt to stop drinking b/c drinking exacerbates ulcer symptoms
- tell pts 5-6 small meals may be preferable to 3 larger meals
- educate pt about signs of GI bleed: black/tarry stools, coffee ground vomitus
- inform pt about S/S of respiratory infection, notify provider if these occur
- for PUD, need dx with visualization of ulcer and test for H. pylori
12
Q
omeprazole: class
A
- proton pump inhibitor (PPI)
13
Q
omeprazole: MOA
A
- undergoes conversion to its active form w/in parietal cells of the stomach
- the active form causes irreversible inhibition of H/K ATPase (proton pump) which is the enzyme that generates gastric acid
- b/c it blocks the final pathway of gastric acid production, it can inhibit basal and stimulated acid release
- see effects w/in 2 hours
- b/c inhibition of the ATPase is not reversible, effects persist until new enzyme synthesized
14
Q
omeprazole: indications
A
- short term therapy of duodenal ulcers, gastric ulcers, erosive esophagitis, and GERD
- long term therapy of hypersecretory conditions (ZE Syndrome)
- prevent stress ulcers (when used in the hospitals), but should only use on pts in ICU and with other risk factors
15
Q
how do PPIs compare to H2RAs?
A
- omeprazole and other PPIs reduce 24 hour acid secretion by 90% compared with 65% for H2RAs
- PPIs also act faster than H2RAs to reduce gastric acidity and relieve ulcer symptoms
- pts who fail to respond to H2RAs can often benefit from PPIs
16
Q
omeprazole: SEs
A
- headache
- diarrhea
- nausea
- vomiting
- all are rare though
17
Q
omeprazole: ADRs
A
- pneumonia b/c of alteration of upper GI flora (due to reduced acid) and impairment of WBC function
- fractures/osteoporosis, b/c reducing acid secretion can dec absorption of calcium
- rebound acid hypersecretion when they stop taking PPIs
- hypomagnesemia b/c reduced Mg absorption
- C. diff
- nephrotoxic
18
Q
omeprazole: nursing implications
A
- contraindicated if hypersensitive to the drug or to component of the formulation
- tx should be limited to 4-8 weeks unless taking for hypersecretory states
- pts should be encouraged to take Ca and vitamin D to prevent osteoporosis
- use for shortest time and in lowest effective dose to prevent rebound dyspepsia
- watch Mg levels and supplement if necessary
- take just before eating
19
Q
misoprostol: class
A
- PG E1 analog
- anti-ulcer drug
20
Q
misoprostol: MOA
A
- prevents NSAID induced ulcers by acting as a replacement for endogenous PG
- PGs protect stomach by suppressing secretion of gastric acids and promotes secretion of bicarbonate and protective mucous
21
Q
misoprostol: indication
A
- prevention of gastric ulcers caused by long term therapy with NSAIDs
- w/ mifepristone, can induce medical termination of pregnancy
22
Q
misoprostol: SEs
A
- dose related diarrhea
- abdominal pain
- spotting
- dysmenorrhea
23
Q
misoprostol: ADRs
A
- miscarriage
24
Q
misoprostol: nursing implications
A
- women of child bearing age must:
- be able to comply with birth control
- be given oral/written warnings about the dangers
- have a negative serum pregnancy test result w/in 2 weeks before beginning therapy
- begin therapy only on 2nd or 3rd day of next normal menstrual cycle
- category X
25
bismuth subsalicylate: class
* anti diarrheals
* anti ulcer
26
bismuth subsalicylate: MOA
* Promotes intestinal adsorption of fluids and electrolytes.
* Decreases synthesis of intestinal prostaglandins.
* act to disrupt the cell wall of H. pylori and cause lysis and death
* also inhibit urease activity and prevent H. pylori from binding to gastric surface
27
bismuth subsalicylate: indications
* Mild to moderate diarrhea.
* Nausea, abdominal cramping, heartburn, and indigestion that may accompany diarrheal illnesses.
* **Treatment of ulcer disease associated with Helicobacter pylori (with anti-infectives).**
* Treatment/prevention of traveler's (enterotoxigenic Escherichia coli) diarrhea.
28
bismuth subsalicylate: SEs
* black tongue
* black stool
29
bismuth subsalicylate: nursing implications
* medication contains aspirin, so do not take any other medications with aspirin
* report any ringing in the ears (tinnitus)
* do not give children b/c of possible Reye's Syndrome
30
metronidazole: class
* anti infective
* anti protozoal
* anti ulcer
31
metronidazole: MOA
* prodrug that is harmless until converted to more chemically active form that only occurs in anaerobic cells
* so does not occur in human cells, since most are aerobic
* interacts with DNA and causes strand breakage and loss of helical structure
32
metronidazole: indications
* symptomatic intestinal amebiasis
* systemic amebiasis
* giardiasis
* trichomoniasis
* E. histolytica
33
metronidazole: SEs
* nausea
* headache
* dry mouth
* metallic taste in mouth
* stomatitis
* vomiting
* diarrhea
* insomnia
* vertigo
* weakness
* darkening of urine
34
metronidazole: ADRs
* hypersensitivity rxns
* Stevens Johnson syndrome
* seizures
* neurologic injury
35
metronidazole: nursing implications
* avoid during 1st trimester of pregnancy and be cautious after
* DO NOT use alcohol for at least 3 days after med is stopped
* be careful is using warfarin
* do not drink grapefruit juice